David J. Benjamin, MD

195 posts

David J. Benjamin, MD banner
David J. Benjamin, MD

David J. Benjamin, MD

@DavidBenjaminMD

Medical oncologist and researcher with interests in genitourinary cancers and health policy. Tweets are my own views, and are not medical advice.

Orange County, CA Katılım Nisan 2021
305 Takip Edilen617 Takipçiler
David J. Benjamin, MD
David J. Benjamin, MD@DavidBenjaminMD·
Thankful to @myESMO for the opportunity to present our study with co-authors @kjmeetswrld @DrMarkLythgoe at #ESMO25 on the state of the global medical oncology workforce. We identified a total of 82,995 medical oncologists in practice across the globe. Disparities exist in accessing an oncologist particularly in lower middle- and low-income countries.
David J. Benjamin, MD tweet media
English
3
10
21
3.1K
David J. Benjamin, MD retweetledi
Enrique Grande
Enrique Grande@drenriquegrande·
🧵 1/ Proud to finally share a paper that took a great deal of effort to write and get published. A global survey sent to 600+ uro-oncologists, with 201 responses from over 30 countries, exploring real-world use of enfortumab vedotin + pembrolizumab (EV-P) in metastatic urothelial carcinoma. 😊 One of the largest initiatives of its kind to date. 🌍 academic.oup.com/oncolo/advance… @UroDocAsh @OncoBellmunt @ProfSyedHussain @AlisonBirtle @raymanneh @dmukherji @amerseburger @DrIacovelli @giannatempopatr @DrYukselUrun @BourlonMaite @cdanicas @DrFelixGuerrero @mflazzaro_gu @ravikanesvaran @DrBenTran @OncoAlert @Larvol @_SEOM @myESMO @urotoday
Enrique Grande tweet media
English
3
21
49
7.5K
David J. Benjamin, MD
David J. Benjamin, MD@DavidBenjaminMD·
Thank you @CancerTodayMag @AACR for featuring our recent @myESMO Real World Data & Digital Oncology study on the portrayal of cancer in public figures in news stories. The public should be cognizant that many news articles lack pertinent details on an individual's diagnosis, prognosis and treatment. This may create unnecessary stress due to the lack of details and general uncertainty in these articles. CC: @drenriquegrande @montypal @PGrivasMDPhD @ArashRezazadeh6
Cancer Today@CancerTodayMag

#ICYMI: What you don’t know about celebrity cancer stories can cause confusion about your own risks or treatment. brnw.ch/21wT46N

English
2
4
16
1.9K
David J. Benjamin, MD
David J. Benjamin, MD@DavidBenjaminMD·
Is the field of genitourinary oncology pivoting away from precision medicine -- and towards imprecision? In @BJUIjournal, @ArashRezazadeh6 and I cite two recent examples of TALAPRO-2 (for metastatic hormone resistant prostate cancer) and EV-302 (for advanced urothelial carcinoma). Both had conference updates suggesting no role for biomarkers despite pre-clinical and trial data suggesting otherwise. This is timely given the FDA ODAC's vote against TALAPRO-2 last week. Our field is at a critical juncture in deciding whether to use biomarkers to pair the right treatment with the right individual. Link: bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…
David J. Benjamin, MD tweet mediaDavid J. Benjamin, MD tweet media
Targeted Oncology@TargetedOnc

BREAKING: The FDA’s ODAC deemed the results from TALAPRO-2 insufficient to conclude a favorable benefit-risk profile for adding talazoparib to enzalutamide in non-HRRm #mCRPC in an 8 to 0 vote. hubs.li/Q03nFR900

English
3
11
28
4.7K
David J. Benjamin, MD retweetledi
Joana Marinho
Joana Marinho@JoanaMarinhOnc·
RWE is crucial for our daily clinical practice! What insightful discussions on mUC treatments! Balancing QoL with efficacy is the key! @drenriquegrande @DavidBenjaminMD
Joana Marinho tweet mediaJoana Marinho tweet mediaJoana Marinho tweet media
English
0
5
20
1.8K
David J. Benjamin, MD
David J. Benjamin, MD@DavidBenjaminMD·
Congratulations to my mentor @ArashRezazadeh6 on receiving the 2025 @UCIMedSchool Faculty Mentor of the Year Award! There is no more deserving individual I know who mentors faculty and trainees across multiple specialities and institutions. Fortunate and grateful for your mentorship, Dr. Rezazadeh!
David J. Benjamin, MD tweet media
English
5
3
39
1.9K
David J. Benjamin, MD
David J. Benjamin, MD@DavidBenjaminMD·
Is the field of oncology overlooking sexual health and reproductive toxicities from cancer therapies? In @TheLancetOncol, @DrMarkLythgoe and I highlight two recent examples, and call for improved monitoring & reporting in clinical trials. Many thanks to the editorial team for selecting our commentary as an Editor's Pick for the April issue. Link: thelancet.com/journals/lanon…
David J. Benjamin, MD tweet media
English
1
9
25
2.2K
David J. Benjamin, MD
David J. Benjamin, MD@DavidBenjaminMD·
How many genitourinary medical oncologists are in the US, and where (region, practice setting, etc.) do they practice? In @urogoldjournal, we find that there are a total of 451 GU medical oncologists in the US, most of whom are men (72.5%). The majority of GU medical oncologists practice in academia (88.5%). In addition, most GU medical oncologists practice in the Northeast followed by the South, West, and Midwest. Of note, seven states have no GU medical oncologist. Link (full text): authors.elsevier.com/a/1kiAnKZx3jmQo
David J. Benjamin, MD tweet mediaDavid J. Benjamin, MD tweet media
English
2
9
28
3.7K
David J. Benjamin, MD retweetledi
Vinay Prasad MD MPH
Vinay Prasad MD MPH@VPrasadMDMPH·
Our paper is out: I found this interesting Some cancers celebs are more likely to admit to having than others. Above the line is over represented reporting in media.
Vinay Prasad MD MPH tweet media
David J. Benjamin, MD@DavidBenjaminMD

Does reading an article about a public figure with cancer leave you with more uncertainty than clarity? In @myESMO Real World Data and Digital Oncology, we review news articles about public figures with cancer from 2010 to 2020. Our study found that most articles lack pertinent details (e.g. type, prognosis, treatment, etc.) on cancer care. Understandably, public figures may choose not to disclose personal aspects of their cancer care. The lack of details and general uncertainty about cancer in these public figures may ultimately lead to more fear and anxiety among readers. CC: @VPrasadMDMPH @vkprasadlab @ArashRezazadeh6 Link (full text): esmorwd.org/article/S2949-…

English
1
2
27
11.3K
David J. Benjamin, MD
David J. Benjamin, MD@DavidBenjaminMD·
Does reading an article about a public figure with cancer leave you with more uncertainty than clarity? In @myESMO Real World Data and Digital Oncology, we review news articles about public figures with cancer from 2010 to 2020. Our study found that most articles lack pertinent details (e.g. type, prognosis, treatment, etc.) on cancer care. Understandably, public figures may choose not to disclose personal aspects of their cancer care. The lack of details and general uncertainty about cancer in these public figures may ultimately lead to more fear and anxiety among readers. CC: @VPrasadMDMPH @vkprasadlab @ArashRezazadeh6 Link (full text): esmorwd.org/article/S2949-…
David J. Benjamin, MD tweet media
English
6
8
33
19.7K
David J. Benjamin, MD retweetledi
Petros Grivas
Petros Grivas@PGrivasMDPhD·
Looking forward to reviewing this editorial. Timely since TROPiCS04 paper coming very soon, stay tuned :-) @tompowles1 @Uromigos @y_loriot @DrScottTagawa @OncoBellmunt @cnsternberg @BladderCancerUS @JoshMeeks @montypal @brian_rini @shilpaonc @apolo_andrea @AbhiTrip87 @OncoAlert
David J. Benjamin, MD@DavidBenjaminMD

Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma? In @EurUrolOncol, we discuss the potential roles of G-CSF, dosing approaches, and differences in patient population compared to the TROPHY-U-01 trial. Link: authors.elsevier.com/a/1kUbL9Cfw03R…

English
0
2
13
1.8K

Keşfet

@myESMO @kjmeetswrld @DrMarkLythgoe @UroDocAsh @OncoBellmunt @ProfSyedHussain @AlisonBirtle @raymanneh